Regulation of the expression of the oncogene EVI1 through the use of alternative mRNA 5′-ends

被引:29
作者
Aytekin, M
Vinatzer, U
Musteanu, M
Raynaud, S
Wieser, R
机构
[1] Med Univ Vienna, KIMCL, Abt Human Genet, A-1090 Vienna, Austria
[2] AKH Vienna, Dept Obstet & Gynecol, Vienna, Austria
[3] Hop Archet, Dept Hematol, Nice, France
基金
奥地利科学基金会;
关键词
EVI1; oncogene; 5 '-end variability; gene expression; mRNA stability;
D O I
10.1016/j.gene.2005.04.032
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The EVII gene plays important roles in development and leukemogenesis. Recently, human EVII has been shown to give rise to at least six different mRNA variants with alternative 5'-ends, only some of which are conserved in mice. In order to gain a basic understanding of the regulation and potential biological importance of these alternative transcripts, we confirmed their expression by Northern blot, and, using real time quantitative RT-PCR, compared their abundance and stability under different conditions. The general expression patterns of the EVII 5'end variants in a panel of 20 human tissues were similar, but particularly high or low levels of some of them were noted in certain tissues. Pronounced differences in the expression of the 5'-end variants were noted in response to all-trans retinoic acid: in a human teratocarcinoma cell line, only the EVII transcript variants containing alternative exons 1a and 1b were upregulated in response to this agent. This induction required transcriptional activity of RNA polymerase, but was also associated with a substantial increase in the stability of these mRNA variants. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:160 / 168
页数:9
相关论文
共 30 条
[1]   Nuclear retinoid receptors and the transcription of retinoid-target genes [J].
Bastien, J ;
Rochette-Egly, C .
GENE, 2004, 328 :1-16
[2]   Stabilization of interleukin-2 mRNA by the c-Jun NH2-terminal kinase pathway [J].
Chen, CY ;
Del Gatto-Konczak, F ;
Wu, ZG ;
Karin, M .
SCIENCE, 1998, 280 (5371) :1945-1949
[3]   Both AML1 and EVI1 oncogenic components are required for the cooperation of AML1/MDS1/EVI1 with BCR/ABL in the induction of acute myelogenous leukemia in mice [J].
Cuenco, GM ;
Ren, RB .
ONCOGENE, 2004, 23 (02) :569-579
[4]   T-cell-derived interleukin-17 regulates the level and stability of cyclooxygenase-2 (COX-2) mRNA through restricted activation of the p38 mitogen-activated protein kinase cascade -: Role of distal sequences in the 3′-untranslated region of COX-2 mRNA [J].
Faour, WH ;
Mancini, A ;
He, QW ;
Di Battista, JA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (29) :26897-26907
[5]   Intergenic splicing of MDS1 and EVI1 occurs in normal tissues as well as in myeloid leukemia and produces a new member of the PR domain family [J].
Fears, S ;
Mathieu, C ;
ZeleznikLe, N ;
Huang, S ;
Rowley, JD ;
Nucifora, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (04) :1642-1647
[6]   Retinoic acid attenuates inducible nitric oxide synthase (NOS2) activation in cultured rat cardiac myocytes and microvascular endothelial cells [J].
Grosjean, S ;
Devaux, Y ;
Seguin, C ;
Meistelman, C ;
Zannad, F ;
Mertes, PM ;
Kelly, RA ;
Ungureanu-Longrois, D .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2001, 33 (05) :933-945
[7]   Establishment of a novel human myeloid leukaemia cell line (HNT-34) with t(3;3)(q21;q26), t(9;22)(q34;q11) and the expression of EVI1 gene, P210 and P190 BCR/ABL chimaeric transcripts from a patient with AML after MDS with 3q21q26 syndrome [J].
Hamaguchi, H ;
Suzukawa, K ;
Nagata, K ;
Yamamoto, K ;
Yagasaki, F ;
Morishita, K .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 98 (02) :399-407
[8]   The Evil proto-oncogene is required at midgestation for neural, heart, and paraxial mesenchyme development [J].
Hoyt, PR ;
Bartholomew, C ;
Davis, AJ ;
Yutzey, K ;
Gamer, LW ;
Potter, SS ;
Ihle, JN ;
Mucenski, ML .
MECHANISMS OF DEVELOPMENT, 1997, 65 (1-2) :55-70
[9]  
Kazama H, 1999, CELL GROWTH DIFFER, V10, P565
[10]   Regulation of gene expression of a binding protein for fibroblast growth factors by retinoic acid [J].
LiaudetCoopman, EDE ;
Wellstein, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (35) :21303-21308